Best Practices in Crisis Management and Business Continuity for BioPharma Manufacturing and Supply Chain Operations
by Best Practices, LLC on Jul 23, 2012
- 1,087 views
Today’s pharma and medical device industries operate in a truly global market environment....
Today’s pharma and medical device industries operate in a truly global market environment.
Now, in the wake of major devastating events (such as the earthquake, tsunami, and partial nuclear meltdown in Japan last year), leading healthcare organizations have moved quickly to ensure their global supply chains and manufacturing operations are capable of sustaining sudden – and potentially ruinous – disruptions and disasters.
This new Best Practices, LLC report examines how world-class companies optimize their Business Continuity and Crisis Management groups and how their response plans fare when faced with major disasters or operating disruptions.
This report is designed to help companies develop an evidence-based understanding of how other companies plan, prevent, prepare and respond to threats to their supply chains and operations – both to keep employees safe and ensure continued production and long-term viability.
The study includes two segments: a Large Healthcare Company segment and a Small Healthcare Company and Clinic segment.
Business Continuity Group Structure & Leadership
Assessing Risks & Prioritizing Response
Securing Your Supply Chain to Safeguard Customers and the Company
Working with Sole-Source or Strategic Suppliers
Creating a Business Resiliency Framework: The Next Generation
Developing a Prevention Mind-set and Fast Response
Using Backups & Redundancy Management
Communication During a Crisis
- Total Views
- Views on SlideShare
- Embed Views